The role of adjuvant combination chemotherapy after cystectomy in locally advanced bladder cancer: What we do not know and why

Annals of Oncology

Volumn 11, Issue 7, 2000, Pages 851-856

  Sylvester, R ^a   Sternberg, C ^b  

^a EORTC DATA CENTER   (Belgium)

^b IRCCS SAN RAFFAELE PISANA   (Italy)

Author keywords

Adjuvant chemotherapy; Bladder cancer; Clinical trials; Cystectomy

Indexed keywords

CISPLATIN; DOXORUBICIN; METHOTREXATE; VINBLASTINE;

ADVANCED CANCER; ARTICLE; BLADDER CANCER; CANCER ADJUVANT THERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; CYSTECTOMY; HUMAN; POSTOPERATIVE CARE; PRIORITY JOURNAL; TREATMENT OUTCOME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; CYSTECTOMY; DISEASE-FREE SURVIVAL; HUMANS; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; RANDOMIZED CONTROLLED TRIALS; REPRODUCIBILITY OF RESULTS; SAMPLE SIZE; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 0033816324     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008399130226     Document Type: Article

References (15)

1. Chemotherapy and management of bladder tumours
2. The role of adjuvant chemotherapy following cystectomy for invasive bladder cancer: A prospective comparative trial
3. Advanced bladder cancer (stages pT3b, pT4a, pN1 and pN2): Improved survival after radical cystectomy and three adjuvant cycles of chemotherapy. Results of a controlled prospective study
4. Adjuvant polychemotherapy of nonorgan-confined bladder cancer after radical cystectomy revisited: Long-term results of a controlled prospective study and further clinical experience
5. A randomized trial of radical cystectomy versus radical cystectomy plus cisplatin, vinblastine and methotrexate chemotherapy for muscle invasive bladder cancer
6. Adjuvant chemotherapy in locally advanced bladder cancer. Final analysis of a controlled multicentre study
7. Adjuvant cisplatin chemotherapy following cystectomy for bladder cancer: Results of a prospective randomized trial
8. Cisplatin as adjunctive treatment for invasive bladder carcinoma: Tolerance and toxicities
9. Evidence-based care
10. The medical review article: State of the science
11. Do authors of review articles use systematic methods to identify, assess and synthesize information?
12. A reversal of fortune: Practical problems in the monitoring and interpretation of an EORTC breast cancer trial
13. Optimal delivery of perioperative chemotherapy: Preliminary results of a randomized, prospective, comparative trial of preoperative and postoperative chemotherapy for invasive bladder carcinoma
14. Randomized phase III trial in advanced urothelial tract tumors of high-dose intensity M-VAC chemotherapy and G-CSF versus classic M-VAC
15. Gemcitabine plus cisplatin, an active regimen in advanced urothelial cancer: A phase II trial of the National Cancer Institute of Canada Clinical Trials Group